|Application ||WB, IHC-P, E|
|Dilution||ELISA (1:1000), IHC-P (10 µg/ml), WB (1:500-1:1000)|
|Other Names||Cyclin-dependent kinase 2-associated protein 1, CDK2-associated protein 1, Deleted in oral cancer 1, DOC-1, Putative oral cancer suppressor, CDK2AP1, CDKAP1, DOC1|
|Target/Specificity||CDKAP1 Antibody detects endogenous levels of total CDKAP1 protein.|
|Reconstitution & Storage||Store at -20°C for up to one year.|
|Precautions||CDK2AP1 Antibody (aa51-100) is for research use only and not for use in diagnostic or therapeutic procedures.|
|Function||specific inhibitor of the cell-cycle kinase CDK2.|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
specific inhibitor of the cell-cycle kinase CDK2.
Daigo Y.,et al.Genes Chromosomes Cancer 20:204-207(1997).
Tsuji T.,et al.J. Biol. Chem. 273:6704-6709(1998).
Arakawa T.,et al.Submitted (MAR-2006) to the EMBL/GenBank/DDBJ databases.
Scherer S.E.,et al.Nature 440:346-351(2006).
Ertekin A.,et al.J. Biol. Chem. 287:16541-16549(2012).
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at email@example.com.